Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-015360
Date:2020-03-01
Issuer: ATARA BIOTHERAPEUTICS, INC. (ATRA)
Original Submission Date:

Reporting Person:

YAREMA KRISTIN
C/O ATARA BIOTHERAPEUTICS, INC.
611 GATEWAY BLVD., SUITE 900 SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-03-01 A 55,000 a $0.00 55,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these restricted stock units vest as to 25% of the shares on march 1, 2021 and the remaining shares vest in 12 equal quarterly installments on each company quarterly vesting date (as defined below) following march 1, 2021, subject to the reporting person's continuous service. company quarterly vesting date means march 1, may 15, august 15 and november 15 of each year.
WhaleWisdom Logo

Elevate your investments